{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:56:14Z","timestamp":1793912174957,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":653,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1111\/ajt.16385","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:00:03Z","timestamp":1604149203000},"page":"846-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000\u20132019 UNOS\/OPTN database"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-4479","authenticated-orcid":false,"given":"Napat","family":"Leeaphorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-3604","authenticated-orcid":false,"given":"Charat","family":"Thongprayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-9988","authenticated-orcid":false,"given":"Api","family":"Chewcharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-4290","authenticated-orcid":false,"given":"Panupong","family":"Hansrivijit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-9519","authenticated-orcid":false,"given":"Caroline C.","family":"Jadlowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreelatha","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-2542","authenticated-orcid":false,"given":"Shennen A.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1814-7003","authenticated-orcid":false,"given":"Michael A.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-9711","authenticated-orcid":false,"given":"Wisit","family":"Cheungpasitporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1111\/ajt.16385_bib1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.16385_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/107424840601100107","article-title":"Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience","volume":"11","author":"Wasson","year":"2006","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"2","key":"10.1111\/ajt.16385_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.16385_bib4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.16385_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0012.1996.tb00437.x","article-title":"Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center","volume":"10","author":"Mihalov","year":"1996","journal-title":"Clin Transplant."},{"issue":"6","key":"10.1111\/ajt.16385_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/ajt.14195","article-title":"Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data","volume":"17","author":"Kotton","year":"2017","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.16385_bib7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/TP.0b013e318270bc7b","article-title":"Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database","volume":"94","author":"Sampaio","year":"2012","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.16385_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/petr.12625","article-title":"Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients","volume":"20","author":"Jordan","year":"2016","journal-title":"Pediatr Transplant."},{"issue":"7","key":"10.1111\/ajt.16385_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1432-2277.2003.tb00343.x","article-title":"A single-centre experience of post-renal transplant lymphoproliferative disorder","volume":"16","author":"Herzig","year":"2003","journal-title":"Transpl Int."},{"issue":"2","key":"10.1111\/ajt.16385_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1526924819835834","article-title":"Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients","volume":"29","author":"Liu","year":"2019","journal-title":"Prog Transplant."},{"issue":"11","key":"10.1111\/ajt.16385_bib11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.16385_bib12","unstructured":"Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on. Cancer. 2017."},{"issue":"4","key":"10.1111\/ajt.16385_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2018.06.009","article-title":"Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients","volume":"94","author":"Francis","year":"2018","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.16385_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/2054358118760831","article-title":"Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort Analysis","volume":"5","author":"Ready","year":"2018","journal-title":"Can J Kidney Health Dis."},{"issue":"2","key":"10.1111\/ajt.16385_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181761659","article-title":"Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder","volume":"86","author":"Swinnen","year":"2008","journal-title":"Transplantation."},{"issue":"8886\u20138887","key":"10.1111\/ajt.16385_bib16","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet."},{"issue":"10","key":"10.1111\/ajt.16385_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":"Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16385_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfx356","article-title":"Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study","volume":"33","author":"Francis","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"10.1111\/ajt.16385_bib19","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1111\/ajt.16385_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/TP.0b013e31823ae7db","article-title":"Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"93","author":"Sampaio","year":"2012","journal-title":"Transplantation."},{"issue":"22","key":"10.1111\/ajt.16385_bib21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2146\/ajhp120770","article-title":"Risk of posttransplant lymphoproliferative disorder associated with use of belatacept","volume":"70","author":"Martin","year":"2013","journal-title":"Am J Health Syst Pharm."},{"issue":"2","key":"10.1111\/ajt.16385_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1111\/ajt.16385_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","article-title":"Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial","volume":"35","author":"Trappe","year":"2017","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1111\/ajt.16385_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ajh.24346","article-title":"Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival","volume":"91","author":"Rosenberg","year":"2016","journal-title":"Am J Hematol."},{"issue":"12","key":"10.1111\/ajt.16385_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2016.09.002","article-title":"Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders","volume":"16","author":"Rosenberg","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"10.1111\/ajt.16385_bib26","first-page":"273","article-title":"Posttransplant lymphoproliferative disorders","volume":"142","author":"Habermann","year":"2008","journal-title":"Cancer Treat Res."},{"issue":"10","key":"10.1111\/ajt.16385_bib27","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/ndt\/gfv260","article-title":"Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients","volume":"30","author":"Taylor","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1111\/ajt.16385_bib28","doi-asserted-by":"crossref","unstructured":"Prasad P, Khullar D, Gupta N, et al. Retransplantation after post transplant lymphoproliferative disorder: overcoming the obstacles!. CEN Case Rep. 2020.","DOI":"10.1007\/s13730-020-00455-z"},{"issue":"10","key":"10.1111\/ajt.16385_bib29","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2215\/CJN.03790417","article-title":"A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders","volume":"12","author":"Caillard","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"10.1111\/ajt.16385_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ctr.12659","article-title":"Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder","volume":"30","author":"Rouphael","year":"2016","journal-title":"Clin Transplant."},{"issue":"11","key":"10.1111\/ajt.16385_bib31","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1600-6143.2006.01543.x","article-title":"Retransplantation after post-transplant lymphoproliferative disorders: an OPTN\/UNOS database analysis","volume":"6","author":"Johnson","year":"2006","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.16385_bib32","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1600-6143.2004.00562.x","article-title":"Successful renal retransplantation after post-transplant lymphoproliferative disease","volume":"4","author":"Karras","year":"2004","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.16385_bib33","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1600-6143.2004.00623.x","article-title":"Retransplantation after post-transplant lymphoproliferative diseases (PTLD): when is it safe?","volume":"4","author":"Hanto","year":"2004","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.16385_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.TP.0000072015.08302.E9","article-title":"Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation","volume":"76","author":"Birkeland","year":"2003","journal-title":"Transplantation."},{"issue":"3","key":"10.1111\/ajt.16385_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s004670050297","article-title":"Retransplantation after post-transplant lymphoproliferative disease","volume":"11","author":"Demircin","year":"1997","journal-title":"Pediatr Nephrol."},{"issue":"13","key":"10.1111\/ajt.16385_bib36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1111\/ajt.16385_bib37","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nature Reviews Disease Primers."},{"issue":"10","key":"10.1111\/ajt.16385_bib38","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder","volume":"15","author":"Luskin","year":"2015","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.16385_bib39","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3109\/10428194.2013.780655","article-title":"Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors","volume":"54","author":"Dierickx","year":"2013","journal-title":"Leuk Lymphoma."},{"issue":"2","key":"10.1111\/ajt.16385_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16385_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol."},{"issue":"8377","key":"10.1111\/ajt.16385_bib42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet."},{"issue":"8","key":"10.1111\/ajt.16385_bib43","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.16385_bib44","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood."},{"issue":"11","key":"10.1111\/ajt.16385_bib45","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3324\/haematol.11360","article-title":"Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease","volume":"92","author":"Gonzalez-Barca","year":"2007","journal-title":"Haematologica."},{"issue":"2","key":"10.1111\/ajt.16385_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.10595","article-title":"CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation","volume":"92","author":"Choquet","year":"2007","journal-title":"Haematologica."},{"issue":"4","key":"10.1111\/ajt.16385_bib47","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1365-2141.2002.03764.x","article-title":"Identification of early antigen BZLF1\/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease","volume":"118","author":"Oertel","year":"2002","journal-title":"Br J Haematol."},{"issue":"9","key":"10.1111\/ajt.16385_bib48","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/JVI.02487-09","article-title":"The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production","volume":"84","author":"Meng","year":"2010","journal-title":"J Virol."},{"issue":"6","key":"10.1111\/ajt.16385_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-Transplantation Lymphoproliferative Disorders in Adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1111\/ajt.16385_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Leblond","year":"2001","journal-title":"J Clin Oncol."},{"issue":"11","key":"10.1111\/ajt.16385_bib51","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12858","article-title":"A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors","volume":"14","author":"Fink","year":"2014","journal-title":"Am J Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16385","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16385","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522084088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522084088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:32:43Z","timestamp":1761629563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522084088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1600613522084088"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16385","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000\u20132019 UNOS\/OPTN database","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}